Cargando…

Association of PTEN expression with biochemical recurrence in prostate cancer: results based on previous reports

PURPOSE: Among men, prostate cancer (PCa) is one of the most commonly diagnosed cancers and the leading cause of cancer death worldwide. Phosphatase and tension homolog (PTEN) acts as a negative regulator of the phosphatidylinositol 3-kinase (PIK3)/Akt pathway and suppresses tumor progression. Meanw...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Haijie, Xie, Bin, Liu, Chunyu, Wang, Jun, Xu, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661465/ https://www.ncbi.nlm.nih.gov/pubmed/29123407 http://dx.doi.org/10.2147/OTT.S132653

Ejemplares similares

Prognostic value of ERG, PTEN, CRISP3 and SPINK1 in predicting biochemical recurrence in prostate cancer
por: NOH, BYEONG-JOO, et al.
Publicado: (2016)

Overexpression of ERG and Wild-Type PTEN Are Associated with Favorable Clinical Prognosis and Low Biochemical Recurrence in Prostate Cancer
por: Kim, Sung Han, et al.
Publicado: (2015)

Assessment of biochemical recurrence of prostate cancer (Review)
por: Lin, Xiaozeng, et al.
Publicado: (2019)

PTEN genomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activity
por: Choucair, Khalil, et al.
Publicado: (2012)

Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers
por: Burdelski, Christoph, et al.
Publicado: (2015)

Effect of Salvage Radiotherapy and Endocrine Therapy on Patients with Biochemical Recurrence After Prostate Cancer Operation— a Meta‑Analysis
por: Yuan, Yong, et al.
Publicado: (2021)

Increased Paxillin expression in prostate cancer is associated with advanced pathological features, lymph node metastases and biochemical recurrence
por: Zheng, Qing-Shui, et al.
Publicado: (2018)

Reduced Connexin 43 expression is associated with tumor malignant behaviors and biochemical recurrence-free survival of prostate cancer
por: Xu, Ning, et al.
Publicado: (2016)

Expression and significance of PTEN and Claudin-3 in prostate cancer
por: Ye, Xinglong, et al.
Publicado: (2019)

Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers
por: Luebke, Andreas M., et al.
Publicado: (2019)

The Effect of Tumor-Prostate Ratio on Biochemical Recurrence after Radical Prostatectomy
por: Cho, Sung Yong, et al.
Publicado: (2016)

PITX2 methylation: a novel and effective biomarker for monitoring biochemical recurrence risk of prostate cancer
por: Jiang, Qi, et al.
Publicado: (2019)

The PTEN Conundrum: How to Target PTEN-Deficient Prostate Cancer
por: Turnham, Daniel J., et al.
Publicado: (2020)

A Novel Ferroptosis-Based Molecular Signature Associated with Biochemical Recurrence-Free Survival and Tumor Immune Microenvironment of Prostate Cancer
por: Ke, Zhi-Bin, et al.
Publicado: (2022)

PTEN loss is associated with prostate cancer recurrence and alterations in tumor DNA methylation profiles
por: Geybels, Milan S., et al.
Publicado: (2017)

Identification of genes that predict the biochemical recurrence of prostate cancer
por: Chu, Jianfeng, et al.
Publicado: (2018)

UDP-glucuronosyltransferases and biochemical recurrence in prostate cancer progression
por: Grant, Delores J., et al.
Publicado: (2017)

Predicting biochemical recurrence of prostate cancer with artificial intelligence
por: Pinckaers, Hans, et al.
Publicado: (2022)

Identification of Potential Predictor of Biochemical Recurrence in Prostate Cancer
por: Wei, Jingchao, et al.
Publicado: (2022)

Salvage brachytherapy for local recurrences of prostate cancer treated previously with radiotherapy
por: Gawkowska-Suwinska, Marzena, et al.
Publicado: (2010)

High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence
por: Nordby, Yngve, et al.
Publicado: (2017)

PUMA and NOXA Expression in Tumor-Associated Benign Prostatic Epithelial Cells Are Predictive of Prostate Cancer Biochemical Recurrence
por: Clairefond, Sylvie, et al.
Publicado: (2020)

DNA demethylation in the PTEN gene promoter induced by 5-azacytidine activates PTEN expression in the MG-63 human osteosarcoma cell line
por: SONG, DEYE, et al.
Publicado: (2014)

Upregulation of Talin-1 expression associates with advanced pathological features and predicts lymph node metastases and biochemical recurrence of prostate cancer
por: Xu, Ning, et al.
Publicado: (2016)

Management of biochemical recurrence after radical prostatectomy for prostate cancer: A case report
por: Shen, Jiayan, et al.
Publicado: (2019)

Decreased expression of bone morphogenetic protein-2 is correlated with biochemical recurrence in prostate cancer: Immunohistochemical analysis
por: Tae, Bum Sik, et al.
Publicado: (2018)

The association between metabolic syndrome and the risk of prostate cancer, high-grade prostate cancer, advanced prostate cancer, prostate cancer-specific mortality and biochemical recurrence
por: Xiang, Yu-zhu, et al.
Publicado: (2013)

Study on the role of SLC14A1 gene in biochemical recurrence of prostate cancer
por: Ye, Bin, et al.
Publicado: (2022)

The effect of the frequency and duration of prostate specific antigen (PSA) measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer
por: Paller, CJ, et al.
Publicado: (2013)

Racial Disparities in Prostate Cancer Incidence, Biochemical Recurrence, and Mortality
por: Bock, Cathryn H., et al.
Publicado: (2011)

MARCKS promotes invasion and is associated with biochemical recurrence in prostate cancer
por: Dorris, Emma, et al.
Publicado: (2017)

Biochemical Recurrence in Prostate Cancer and Temporal Association to Bone Metastasis
por: Mahdy, Ayman, et al.
Publicado: (2019)

Genomic Rearrangements of PTEN in Prostate Cancer
por: Phin, Sopheap, et al.
Publicado: (2013)

Association of molecular biomarkers expression with biochemical recurrence in prostate cancer through tissue microarray immunostaining
por: MA, DING, et al.
Publicado: (2015)

Mutation and expression analysis of the putative prostate tumour-suppressor gene PTEN.
por: Gray, I. C., et al.
Publicado: (1998)

The Value of Multimodality PET/CT Imaging in Detecting Prostate Cancer Biochemical Recurrence
por: Jiang, Jie, et al.
Publicado: (2022)

Biochemical Recurrence in Prostate Cancer Is Associated with the Composition of Lactobacillus: Microbiome Analysis of Prostatic Tissue
por: Kim, Jae Heon, et al.
Publicado: (2023)

One-year experience with (68)Ga-PSMA PET/CT: applications and results in biochemical recurrence of prostate cancer
por: Prado Júnior, Luciano Monteiro, et al.
Publicado: (2018)

Texture Analysis of F-18 Fluciclovine PET/CT to Predict Biochemically Recurrent Prostate Cancer: Initial Results
por: Kang, Hakmook, et al.
Publicado: (2020)

PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort
por: Lotan, Tamara L., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_adkr5k76gbv95okr9ruhc1achs